PET/SPECT/CT Camera for Small Animal Imaging at UMMS
PET/SPECT/CT Camera for Small Animal Imaging at UMMS
批准号:
7125665
负责人:
DONALD J HNATOWICH
金额:
$87.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2008-05-31
关键词:
AddressAdministratorAdvisory CommitteesAnatomyAnimalsBiodistributionBiologicalCell NucleusCollaborationsConflict (Psychology)Core FacilityDepthDetectionDevelopmentDiagnosticDiscipline of Nuclear MedicineDoctor of PhilosophyEventFacultyFundingGoalsGrantImageInfectionInflammationInvasiveIodine RadioisotopesLabelLeadMeasurementMethodsModalityMolecular MedicineOpticsPhotonsPhysiologicalPositron-Emission TomographyProteomicsRadioactivityRadioisotopesReportingResearchResearch PersonnelResolutionScientistSystemTechnologyTimeTissuesTracerUnited States National Institutes of HealthUniversitiesX-Ray Computed Tomographyanimal careexperienceimprovedin vivoinstrumentinstrumentationinterestmembermolecular imagingsingle photon emission computed tomographytomographytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Interest in small animal imaging has grown in recent years in step with developments in molecular medicine and, in particular, with the emergence of molecular imaging. Modalities such as positron emission tomography (PET) and single photon emission tomography (SPECT) are of considerable value to researchers concerned with external noninvasive imaging of molecular events in vivo. The much higher sensitivities of both SPECT and PET make possible in vivo imaging of tracers at physiological concentrations not possible at present with any other technology especially in deep tissues. While small animal imaging with PET has certainly proven its worth, SPECT offers many advantages including the ability to perform dual labeling studies, the potential for higher intrinsic resolution, 99mTc, the most useful radionuclide in diagnostic nuclear medicine, and iodine radioisotopes (125I and 123I) critical for emerging in vivo proteomics research. NIH-funded investigators and others supporting this application have need for radioactivity measurements in small animals. In some cases, these measurements will benefit from, if not require, the tomographic imaging capability or the higher resolution of a small animal PET/SPECT camera. In all cases, superior spatial and temporal biodistributions will be obtained with the sacrifice of fewer animals. That a single animal can act as its own control is a major advantage, for example in tumor and infection/inflammation studies in which the imaging target tissue is difficult to standardize. The co-registration of radioactivity distribution with anatomy by X-ray computed tomography (CT) is an invaluable asset not yet available commercially in all but one small animal PET camera. In summary, the advantage of PET and SPECT for non-invasive in vivo animal imaging is the vastly higher sensitivity for the detection of biological tracers especially in deep tissues. The preferred method of performing animal biodistributions is animal imaging and the preferred method of animal imaging is on a dedicated small animal camera with matching spatial resolution. We wish to purchase the GammaMedica PET/SPECT/CT camera, the only commercially available small animal camera capable of both PET and SPECT, and equipped with CT capability for anatomical registration and quantitation. This application describes an administration plan with a chain of command from a full-time PhD scientist reporting to a faculty member administrator, both of whom will report to the P.I. who, in turn, will report to an advisory committee. Questions of camera usage and methods of encouraging imaging at UMMS will be considered by the advisory committee of users and non-users that includes members with experience in animal care, administration, conflict resolution and small animal imaging. The P. I. and his collaborators wish to use the High-End Instrumentation Grant as a vehicle to establish the nucleus of a core facility at UMMS for small animal imaging. We believe that this application addresses the goals of the NIH in offering the RFA and the goals of UMMS to expand use on our campus of small animal imaging.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/bc1001467
发表时间:
2010-08-18
期刊:
BIOCONJUGATE CHEMISTRY
影响因子:
4.7
作者:
[Cheng, Dengfeng, Wang, Yi, Liu, Xinrong, Pretorius, P. Hendrik, Liang, Minmin, Rusckowski, Mary, Hnatowich, Donald J.]
通讯作者:
Hnatowich, Donald J.
Optical Antisense Breast Tumor Targeting
-
批准号:7293968
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2007
-
负责人:DONALD J HNATOWICH
-
依托单位:
Optical Antisense Breast Tumor Targeting
-
批准号:7456519
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2007
-
负责人:DONALD J HNATOWICH
-
依托单位:
Imaging Survivin mRNA for Cancer Detection
-
批准号:6731349
-
项目类别:
-
资助金额:$17.89万
-
财政年份:2004
-
负责人:DONALD J HNATOWICH
-
依托单位:
Imaging Survivin mRNA for Cancer Detection
-
批准号:6887708
-
项目类别:
-
资助金额:$17.89万
-
财政年份:2004
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Radiotherapy by MORF pretargeting
-
批准号:6698513
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Rediotherapy by MORF Pretargeting
-
批准号:7555377
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Rediotherapy by MORF Pretargeting
-
批准号:7258505
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Radiotherapy by MORF pretargeting
-
批准号:6622876
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Radiotherapy by MORF Pretargeting
-
批准号:7754656
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Radiotherapy by MORF pretargeting
-
批准号:6845715
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Rediotherapy by MORF Pretargeting
-
批准号:7390652
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Improved Tumor Radiotherapy by MORF pretargeting
-
批准号:6458725
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2002
-
负责人:DONALD J HNATOWICH
-
依托单位:
Future of Molecular Medicine
-
批准号:6515246
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2001
-
负责人:DONALD J HNATOWICH
-
依托单位:
Future of Molecular Medicine
-
批准号:6406263
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2001
-
负责人:DONALD J HNATOWICH
-
依托单位:
INTERFACE OF MOLECULAR BIOLOGY AND NUCLEAR MEDICINE
-
批准号:6158332
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2000
-
负责人:DONALD J HNATOWICH
-
依托单位:
AMPLIFYING TC99M IN TUMOR USING PNA POLYMERS
-
批准号:6489156
-
项目类别:
-
资助金额:$32.09万
-
财政年份:1999
-
负责人:DONALD J HNATOWICH
-
依托单位:
AMPLIFYING TC99M IN TUMOR USING PNA POLYMERS
-
批准号:2725111
-
项目类别:
-
资助金额:$30.34万
-
财政年份:1999
-
负责人:DONALD J HNATOWICH
-
依托单位:
MOLECULAR BIOLOGY FOR THE NUCLEAR MEDICINE SPECIALIST
-
批准号:2881525
-
项目类别:
-
资助金额:$0.4万
-
财政年份:1999
-
负责人:DONALD J HNATOWICH
-
依托单位:
AMPLIFYING TC99M IN TUMOR USING PNA POLYMERS
-
批准号:6137682
-
项目类别:
-
资助金额:$29.65万
-
财政年份:1999
-
负责人:DONALD J HNATOWICH
-
依托单位:
AMPLIFYING TC99M IN TUMOR USING PNA POLYMERS
-
批准号:6342106
-
项目类别:
-
资助金额:$31.54万
-
财政年份:1999
-
负责人:DONALD J HNATOWICH
-
依托单位:
海外基金